BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 20205103)

  • 21. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk-oriented approach to hereditary adrenal pheochromocytoma.
    Machens A; Brauckhoff M; Gimm O; Dralle H
    Ann N Y Acad Sci; 2006 Aug; 1073():417-28. PubMed ID: 17102110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?
    Jiménez C; Cote G; Arnold A; Gagel RF
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2851-8. PubMed ID: 16735498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
    Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
    Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comprehensive next generation sequencing-based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma.
    Rattenberry E; Vialard L; Yeung A; Bair H; McKay K; Jafri M; Canham N; Cole TR; Denes J; Hodgson SV; Irving R; Izatt L; Korbonits M; Kumar AV; Lalloo F; Morrison PJ; Woodward ER; Macdonald F; Wallis Y; Maher ER
    J Clin Endocrinol Metab; 2013 Jul; 98(7):E1248-56. PubMed ID: 23666964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
    Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
    JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas.
    Klein RD; Jin L; Rumilla K; Young WF; Lloyd RV
    Diagn Mol Pathol; 2008 Jun; 17(2):94-100. PubMed ID: 18382370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx.
    Gimm O
    Fam Cancer; 2005; 4(1):17-23. PubMed ID: 15883706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients.
    Cascón A; Inglada-Pérez L; Comino-Méndez I; de Cubas AA; Letón R; Mora J; Marazuela M; Galofré JC; Quesada-Charneco M; Robledo M
    Endocr Relat Cancer; 2013 Jun; 20(3):L1-6. PubMed ID: 23404858
    [No Abstract]   [Full Text] [Related]  

  • 30. Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes.
    Pęczkowska M; Kowalska A; Sygut J; Waligórski D; Malinoc A; Janaszek-Sitkowska H; Prejbisz A; Januszewicz A; Neumann HP
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):817-23. PubMed ID: 23551045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation screening in a Norwegian cohort with pheochromocytoma.
    Sjursen W; Halvorsen H; Hofsli E; Bachke S; Berge A; Engebretsen LF; Falkmer SE; Falkmer UG; Varhaug JE
    Fam Cancer; 2013 Sep; 12(3):529-35. PubMed ID: 23407919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomas.
    Shankavaram U; Fliedner SM; Elkahloun AG; Barb JJ; Munson PJ; Huynh TT; Matro JC; Turkova H; Linehan WM; Timmers HJ; Tischler AS; Powers JF; de Krijger R; Baysal BE; Takacova M; Pastorekova S; Gius D; Lehnert H; Camphausen K; Pacak K
    Neoplasia; 2013 Apr; 15(4):435-47. PubMed ID: 23555188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic mutation analysis of the SDHB, SDHC, SDHD, and RET genes in the clinical assessment of sporadic and hereditary pheochromocytoma.
    Weber A; Hoffmann MM; Neumann HP; Erlic Z
    Horm Cancer; 2012 Aug; 3(4):187-92. PubMed ID: 22573489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pheochromocytoma: the expanding genetic differential diagnosis.
    Bryant J; Farmer J; Kessler LJ; Townsend RR; Nathanson KL
    J Natl Cancer Inst; 2003 Aug; 95(16):1196-204. PubMed ID: 12928344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor.
    Elder EE; Elder G; Larsson C
    J Surg Oncol; 2005 Mar; 89(3):193-201. PubMed ID: 15719371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial pheochromocytoma.
    Erlic Z; Neumann HP
    Hormones (Athens); 2009; 8(1):29-38. PubMed ID: 19269919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial nonsyndromic pheochromocytoma.
    Opocher G; Schiavi F; Iacobone M; Toniato A; Sattarova S; Erlic Z; Martella M; Mian C; Merante Boschin I; Zambonin L; De Lazzari P; Murgia A; Pelizzo MR; Favia G; Mantero F
    Ann N Y Acad Sci; 2006 Aug; 1073():149-55. PubMed ID: 17102081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas.
    López-Jiménez E; Gómez-López G; Leandro-García LJ; Muñoz I; Schiavi F; Montero-Conde C; de Cubas AA; Ramires R; Landa I; Leskelä S; Maliszewska A; Inglada-Pérez L; de la Vega L; Rodríguez-Antona C; Letón R; Bernal C; de Campos JM; Diez-Tascón C; Fraga MF; Boullosa C; Pisano DG; Opocher G; Robledo M; Cascón A
    Mol Endocrinol; 2010 Dec; 24(12):2382-91. PubMed ID: 20980436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pheochromocytoma in von Hippel-Lindau disease and neurofibromatosis type 1.
    Opocher G; Conton P; Schiavi F; Macino B; Mantero F
    Fam Cancer; 2005; 4(1):13-6. PubMed ID: 15883705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours.
    Srirangalingam U; Khoo B; Walker L; MacDonald F; Skelly RH; George E; Spooner D; Johnston LB; Monson JP; Grossman AB; Drake WM; Akker SA; Pollard PJ; Plowman N; Avril N; Berney DM; Burrin JM; Reznek RH; Kumar VK; Maher ER; Chew SL
    Endocr Relat Cancer; 2009 Jun; 16(2):515-25. PubMed ID: 19208735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.